http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cb99a44076d5a6ebac5b30322a6ebf5
Outgoing Links
Predicate | Object |
---|---|
family-name | Yano |
name | Seiji Yano |
given-name | Seiji |
organization-name | Department of Respiratory Medicine, Kanazawa University Hospital, Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa 920-0934, Japan 6Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. Department of Respiratory medicine Kanazawa Graduate school of Medical Sciences Kanazawa Japan Division of Medical Oncology Kanazawa University Cancer Research Institute Kanazawa Japan Authors' Affiliations: 1Division of Medical Oncology; 2Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa; 3Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo; 4Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for... Department of Internal Medicine and Molecular Therapeutics , University of Tokushima Graduate School, Tokushima, Japan Authors' Affiliations: Divisions of 1Surgical Oncology and 2Medical Oncology, Cancer Research Institute, Kanazawa University; and 3Kanazawa Medical Center, Kanazawa, Japan Division of Medical Oncology Cancer Research Institute, Kanazawa University Kanazawa Japan Division of Medical Oncology, Cancer Research Institute Kanazawa University Kanazawa Japan Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School 1Internal Medicine and Molecular Therapeutics; Department of; 5Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa, Japan; Cancer Research Institute,Kanazawa University,Kanazawa,Japan Department of Medical Oncology, Kanazawa University Cancer Research Institute, Kanazawa, Japan Authors' Affiliations: Divisions of 1Medical Oncology and 2Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Ishikawa, Japan; 3Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan; and 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan Third Department of Internal Medicine, The University of Tokushima , Kuramoto-cho, Tokushima , Japan Department of Internal Medicine and Molecular Therapeutics, University of Tokushima School of Medicine, Tokushima, 3-18-15 Kuramoto-cho, Tokushima, Japan The Third Department of Internal Medicine, The University of Tokushima School of Medicine , Tokushima Division of Medical Oncology Cancer Research Institute, Kanazawa University Kanazawa Japan; Department of Respiratory Medicine Faculty of Medicine Institute of Medical, Pharmaceutical, and Health Sciences Kanazawa Japan; WPI‐Nano Life Science Institute (WPI‐Nano LSI) Kanazawa University Kanazawa Japan Department of Internal Medicine and Molecular Therapeutics, University of Tokushima Graduate School, Tokushima 770-8503, Japan Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755‑8505, Japan The University of Tokushima Graduate School of Medicine, Tokushima, Japan Division of Medical Oncology Cancer Research Institute Kanazawa University Kanazawa Japan Authors' Affiliations: Divisions of 1Medical Oncology and 2Tumor Dynamics and Regulation, Cancer Research Institute, and 3Department of General and Cardiothoracic Surgery, Kanazawa University, Kanazawa, Ishikawa, Japan; 4Saito Laboratory, Kringle Pharma, Inc., Saitoasagi, Ibaraki, Osaka, Japan; and 5Department of Internal Medicine and Molecular Therapeutics, University of Tokushima Graduate School, Tokushima, Tokushima, Japan *Department of Internal Medicine and Molecular Therapeutics, University of Tokushima School of Medicine, Tokushima, Japan WPI-Nano Life Science Institute, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan Division of Medical Oncology Cancer Research Institute, Kanazawa University Dept. of Medical Oncology, Cancer Research Institute, Kanazawa University. Authors' Affiliations: Divisions of 1Medical Oncology and 2Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 3Departments of Thoracic Surgery, Aichi Cancer Center Hospital; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan Department of Digestive and General Surgery Shimane University Faculty of Medicine Izumo Japan WPI-Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Japan Authors' Affiliations: 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 2Tsukuba Research Laboratories, Eisai co., ltd., Ibaraki; 3Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; and 4Division of Functional Genomics, Jichi Medical University, Shimotsuke, Tochigi, Japan 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa, Japan. 1Department of Internal Medicine and Molecular Therapeutics, Course of Medical Oncology, University of Tokushima Graduate School, Tokushima, Japan; and 2Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. Kanazawa University 13-1 Takara-machi, Kanazawa-City, Ishikawa, Japan Authors' Affiliations: Departments of 1Respiratory Medicine and Rheumatology, 2Medical Oncology, and 3Molecular and Environmental Pathology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima; 4Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa; and 5Discovery Department, Oncology PCU, Eisai Product Creation Systems, Research Laboratories, Eisai Co. Ltd., Ibaraki, Japan 3Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa, Japan Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755-8505, Japan Division of Medical Oncology Cancer Research Institute, Kanazawa University, Japan. Division of Medical Oncology, Cancer Research Institute, Kanazawa University. Kanazawa, Ishikawa 920-0934, Japan. syano@staff.kanazawa-u.ac.jp Division of Medical Oncology, Cancer Research Institute, Kanazawa University; Innovative Clinical Research Center (iCREK), Kanazawa University Hospital Department of Internal Medicine and Molecular Therapeutics, Course of Bioregulation and Medical Oncology, The University of Tokushima School of Medicine Cancer Center, Kanazawa University Hospital, Japan Department of Urology Graduate School of Medicine Yamaguchi University Ube Japan Third Department of Internal Medicine, The University of Tokushima School of Medicine Third Department of Internal Medicine, University of Tokushima School of Medicine, Tokushima, Japan. #Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa 920-0934, Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University Department of Internal Medicine and Molecular Therapeutics, Course of Bioregulation and Medical Oncology, University of Tokushima School of Medicine, Tokushima, Japan. Division of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. Cancer Center, Kanazawa University School of Medicine, Kanazawa, Japan Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Gradate School; Division of Medical Oncology, Cancer Research Institute, Kanazawa University Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Division of Medical Oncology Cancer Research Institute Kanazawa University Kanazawa Japan; Nano Life Science Institute Kanazawa University Kanazawa Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Ishikawa, Japan. Department of Digestive and General Surgery Shimane University Faculty of Medicine Izumo Shimane Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; Nano Life Science Institute, Kanazawa University, Kanazawa, Japan Division of Medical Oncology Cancer Research Institute Kanazawa University Kanazawa Ishikawa Japan Authors' Affiliations: 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 2Department of Respiratory Medicine, Nagoya University; 3Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi; and 4Tsukuba Research Laboratories, Eisai Co., ltd., Ibaraki, Japan 1Medical Oncology and Divisions of Chemotherapy Center, Houju Memorial Hospital; Department of Medical Oncology, Kanazawa University Cancer Research Institute, Kanazawa University Authors' Affiliations: Divisions of 1Medical Oncology, 2Tumor Dynamics and Regulation, and 3Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 4Department of Respiratory Medicine and Rheumatology, University of Tokushima Graduate School, Tokushima, Tokushima; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan Department of Urology, Graduate School of Medicine Yamaguchi University Ube Yamaguchi Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-0934, Japan. 1Division of Medical Oncology, Kanazawa University Cancer Research Institute, Kanazawa, Japan. 1Internal Medicine and Molecular Therapeutics and Departments of Division of Medical Oncology, Cancer Research Institute, Kanazawa University. Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.; 6WPI-Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kanazawa, Japan. Department of Internal Medicine and Molecular Therapeutics, The University of Tokushima Graduate School Authors' Affiliations: Departments of 1Respiratory Medicine and Rheumatology and 2Molecular and Environmental Pathology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan; 3Division of Medical Oncology, Molecular and Cellular Targeting Translational Oncology Center, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan Department of Respiratory Medicine Kanazawa University Hospital Kanazawa Japan Division of Medical Oncology Cancer Research Institute Kanazawa University Ishikawa 1Internal Medicine and Molecular Therapeutics; Departments of; 3Division of Medical Oncology, Molecular and Cellular Targeting Translational Oncology Center, Cancer Research Institute, Kanazawa University, Ishikawa, Japan Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Japan |
Incoming Links
Total number of triples: 349.